SEC Form 4 · accession 0001209191-19-014250
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis T Williams
Director
Period of report
Feb 26, 2019
Accepted (ET)
Feb 27, 2019 · 7:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | F | 926 | $11.95 | D | 461,360 | D |
Table II — derivative securities
No Table II lines on this filing.